← SynDRA
TODRALAZINE
SynDRA canonical compound SYN0020887 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | antihypertensive agent |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP1A2
- HDAC6
- TDP1
- SLCO1B3
- SLCO1B1
- SAMHD1
- LMNA
- IDH1
- HIF1A
- GMNN
- CYP2C19
- GLS
- GALC
- FAAH
- EHMT2
- CYP3A4
- CYP2D6
- CYP2C9
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antihypertensive Agents
- Cardiovascular Agents
- antihypertensive agent
Cross-references
Synonyms
- carboethoxyphthalazinohydrazine
- todralazine hydrochloride
- todralazine HCl
- Todralazina
- BT-621 FREE BASE
- CEPH
- CEPH FREE BASE
- NSC-757868
- Ecarazine
- Ethyl 3-(1-phthalazinyl)carbazate
- WEN3K83YKD
- NSC 757868
- Todrazoline
- RefChem:190269
- DTXCID8025048
- Todralacina
- Carboethoxyphthalazinohydrazine
- 3-(1-Phthalazinyl)carbazic acid ethyl ester
- BT-621
- CARBAZIC ACID, 3-(1-PHTHALAZINYL)-, ETHYL ESTER
- Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester
- Binazin
- Todralacina [Spanish]
- Todralazinum
- Todralazine [INN:BAN]
- Todralazinum [INN-Latin]
- Todralazina [INN-Spanish]
- ethyl N-(phthalazin-1-ylamino)carbamate
- NCGC00016640-03
- UNII-WEN3K83YKD
- CAS-3778-76-5
- N-Carboethoxy-N'-phthalazino-hydrazine
- BRN 0233300
- Todralazine (BAN)
- Binazine (Salt/Mix)
- Ecarazine (Salt/Mix)
- Spectrum_001187
- Todrazoline (Salt/Mix)
Look up TODRALAZINE in the interactive SynDRA portal →